Literature DB >> 1649832

Proteolysis of nuclear proteins by mu-calpain and m-calpain.

R L Mellgren1.   

Abstract

Purified calpains are capable of proteolyzing several high Mr nuclear proteins and solubilizing a histone H1 kinase activity from rat liver nuclei upon exposure to 10(-6) - 10(-5) M Ca2+. Major nuclear substrates displayed apparent molecular masses of 200, 130, 120, and 60 kDa on Coomassie Blue-stained SDS-PAGE gels. The nuclear proteins and the H1 kinase were released from Triton-treated nuclei following incubation with buffer containing 0.5 M NaCl. They therefore appeared to be internal nuclear matrix proteins. The nuclear H1 kinase activity solubilized by incubation with m-calpain was eluted in the void volume of a Bio-Gel A-1.5m column, indicating an apparent mass greater than 1,500 kDa. Treatment of the calpain-solubilized kinase with 0.5 M NaCl dissociated it to a form having an apparent mass of 300 kDa (Stokes radius = 5.6 nm), suggesting that the 300-kDa (Stokes radius = 5.6 nm), nuclei by calpain treatment as a large complex containing other internal matrix proteins. Purified human erythrocyte mu-calpain was capable of proteolyzing the nuclear matrix proteins at 10(-6) M Ca2+. In contrast, human erythrocyte multicatalytic protease complex produced little cleavage of the nuclear proteins. Proteolysis of nuclear proteins by either mu-calpain or m-calpain was inhibited by calpastatin. These experiments suggest a physiologic role for the calpains in the turnover of nuclear proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

3.  Proteolysis of the human DNA polymerase epsilon catalytic subunit by caspase-3 and calpain specifically during apoptosis.

Authors:  W Liu; S Linn
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

Review 4.  N-myristoyltransferase.

Authors:  R V Rajala; R S Datla; T N Moyana; R Kakkar; S A Carlsen; R K Sharma
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

5.  Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase.

Authors:  Zhaoqiang Cui; Zhaosheng Han; Zhaozhong Li; Hanbo Hu; Jawaharlal M Patel; Veena Antony; Edward R Block; Yunchao Su
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-11       Impact factor: 6.914

6.  Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases.

Authors:  Ronald L Mellgren; Katsuya Miyake; Irina Kramerova; Melissa J Spencer; Nathalie Bourg; Marc Bartoli; Isabelle Richard; Peter A Greer; Paul L McNeil
Journal:  Biochim Biophys Acta       Date:  2009-09-23

7.  Autolysis parallels activation of mu-calpain.

Authors:  A Baki; P Tompa; A Alexa; O Molnár; P Friedrich
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Specific cleavage of transcription factors by the thiol protease, m-calpain.

Authors:  F Watt; P L Molloy
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

Review 9.  Calcium and calcium-binding proteins in the nucleus.

Authors:  J S Gilchrist; M P Czubryt; G N Pierce
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

10.  Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.